Related Experiment Video

Updated: May 2, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

1.7K

Asymptomatic coronary artery disease in type II diabetes

Paramdeep S Baweja, Pratik B Sandesara, M Javed Ashraf

    Missouri Medicine
    |March 21, 2014
    PubMed

    Insights

    Diabetics often have silent coronary artery disease (CAD), posing a diagnostic challenge. This review proposes a step-wise approach to risk-stratify and screen for silent myocardial ischemia in diabetic patients.

    Area of Science:

    • Cardiology
    • Diabetology
    • Preventive Medicine

    Background:

    • Coronary artery disease (CAD) is a leading cause of death and disability in patients with diabetes mellitus.
    • Asymptomatic CAD is prevalent in diabetics, presenting a diagnostic challenge due to the absence of typical symptoms.
    • Current screening algorithms for silent myocardial ischemia in diabetic populations are lacking.

    Purpose of the Study:

    • To review diagnostic tools for assessing coronary artery disease in diabetic patients.
    • To propose a structured, step-wise approach for risk stratification of silent myocardial ischemia in this high-risk group.

    Main Methods:

    • Review of existing literature on diagnostic modalities for CAD in diabetes.
    • Development of a proposed risk stratification algorithm based on current evidence.

    Main Results:

    • The review highlights various diagnostic tools available for CAD assessment in diabetics.
    • A step-wise approach for risk stratification is proposed to aid in identifying patients with silent myocardial ischemia.

    Conclusions:

    • Effective screening and risk stratification are crucial for managing asymptomatic CAD in diabetes mellitus.
    • The proposed approach aims to improve early detection and management of silent myocardial ischemia, reducing associated morbidity and mortality.

    More Related Videos

    Isolation of Murine Coronary Vascular Smooth Muscle Cells08:24

    Isolation of Murine Coronary Vascular Smooth Muscle Cells

    Published on: May 30, 2016

    14.0K
    Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes07:22

    Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

    Published on: March 7, 2025

    1.2K

    Related Concept Videos

    Type II Diabetes II: Pathophysiology01:24

    Type II Diabetes II: Pathophysiology

    PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
    28
    Coronary Artery Disease II: Pathophysiology01:26

    Coronary Artery Disease II: Pathophysiology

    Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
    1.1K
    Type I Diabetes II: Pathophysiology01:26

    Type I Diabetes II: Pathophysiology

    Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
    75
    Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

    Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

    Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated...
    17
    Coronary Artery Disease I: Introduction01:30

    Coronary Artery Disease I: Introduction

    Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
    1.8K
    Type II Diabetes I: Introduction01:26

    Type II Diabetes I: Introduction

    Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
    17